We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sugar-Coated Proteins Trigger Insulin Resistance

By Biotechdaily staff writers
Posted on 24 May 2002
Newly published research shows that intracellular glycosylation of proteins may initiate insulin resistance, a key feature of diabetes. More...
The report in the April 16, 2002, issue of the Proceedings of the National Academy of Sciences describes how proteins involved in the insulin pathway fail to work properly after becoming coated with too many sugar molecules.

Type 2 diabetes, the most common form in adults, occurs when muscle, fat and other tissues stop responding to insulin's signals to remove excess sugar from the blood. "Cells do not respond to insulin itself. Instead, a whole cascade of events, set in motion by insulin, eventually causes cells to take in sugar,” explains Dr. Gerald Hart of Johns Hopkins University (Baltimore, MD, USA; www.jhu.edu). "We now have an explanation of how sugar can affect these signals, and even a hypothesis for how high blood sugar could cause tissue damage in diabetes--by improperly modifying proteins.”

The research team developed new methods for analyzing simple sugars with special emphasis on O-linked beta-N-acetylglucosamine (O-GlcNAc), which is frequently used by the cell nucleus and protoplasm to label proteins and modify their behavior. In the current study, the scientists employed a blocker called PUGNAc to force the glycosylation of cellular proteins without adding extra sugar, as had been done by others to create insulin resistance.

Not only did the blocker increase the amount of O-GlcNAc bound to proteins, but also the increase caused the cells to stop responding to insulin. Two proteins from the insulin-signaling pathway, beta-catenin and insulin receptor substrate-1 (IRS-1), were found to be more glycosylated than normal. The researchers suspect that the ability of these proteins to function is adversely affected by the extra sugars they carry. Thus, increasing O-GlcNAc on proteins is, by itself, a cause of insulin resistance, rather than an effect or a coincidence.



Related Links:
Johns Hopkins University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.